Drug Profile
Research programme: retinoic acid inducible gene I protein stimulants - Kineta
Alternative Names: Research programme: DDX58 protein stimulants - Kineta; Research programme: RIG-I protein stimulants - KinetaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kineta
- Class Small molecules; Vaccines
- Mechanism of Action DDX58 protein stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections